Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier
International Journal of Hematology, 10/13/09
Fujimoto K et al. – This is the first report that a complete remission was achieved in a patient with SMZL after a hepatitis B flare–up. The clinical course of this patient suggests that an immune response against HBV also affects the clearance of lymphoma cells.
Related Articles
Subcutaneous ‘lipoma-like’ B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT
Annals of Oncology, 10/29/09
Relevance Score: 95%
Relapsed or refractory nongastric marginal zone B-cell lymphoma: Multicenter retrospective analysis of 92 cases
American Journal of Hematology, 11/09/09
Relevance Score: 94%
Primary cutaneous marginal zone lymphoma
Critical Reviews in Oncology/Hematology, 10/15/09
Relevance Score: 94%
Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkins Lymphoma
Journal of Clinical Oncology, 10/08/09
Relevance Score: 94%
Anetoderma in cutaneous marginal-zone B-cell lymphoma
Clinical and Experimental Dermatology, 10/06/09
Relevance Score: 93%
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Features and Treatment Outcomes of Non-Hodgkin's Lymphomas Involving Rare Extranodal Sites: A Single-Center Experience
Acta Haematologica, 12/04/09
Phase I Clinical and Pharmacokinetic Study of Oral Sapacitabine in Patients With Acute Leukemia and Myelodysplastic Syndrome
Journal of Clinical Oncology, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


